2013
DOI: 10.1016/j.jim.2012.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Low cost, disposable biosensors allow detection of antibodies with results equivalent to ELISA in 15min

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 12 publications
0
10
0
1
Order By: Relevance
“…Biosensors are a promising alternative to expensive conventional medical diagnostic techniques commonly employed in clinical laboratories such as enzyme-linked immunosorbent assays (ELISA) or Western blots. Compared to such techniques, biosensors have the advantage of being cost effective, quick, and portable and therefore suitable for point-of-care testing (POCT). Although some specific biosensors are already present in the market, including, for example, glucose monitoring, they are not widely employed yet to screen biomarkers for early diagnosis of diseases . Of all classes of sensing strategies, optical biosensors are a promising choice for early diagnostics, as they have the potential for low cost, rapid response, and high reliability. ,, Furthermore, significant research effort is currently focused on developing multiplexed architectures to increase the number of biomarkers that could be screened simultaneously to improve the confidence interval of the analysis. However, for current clinical techniques such as ELISA, a major cost lies in the quantity of reagents, particularly antibodies, required to functionalize the surface. , Although significant focus is given in the literature on ways of improving biosensor performance, little attention has been paid to date to creating sensing architectures that limit the quantity of reagents required for analysis without loss in sensitivity or specificity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Biosensors are a promising alternative to expensive conventional medical diagnostic techniques commonly employed in clinical laboratories such as enzyme-linked immunosorbent assays (ELISA) or Western blots. Compared to such techniques, biosensors have the advantage of being cost effective, quick, and portable and therefore suitable for point-of-care testing (POCT). Although some specific biosensors are already present in the market, including, for example, glucose monitoring, they are not widely employed yet to screen biomarkers for early diagnosis of diseases . Of all classes of sensing strategies, optical biosensors are a promising choice for early diagnostics, as they have the potential for low cost, rapid response, and high reliability. ,, Furthermore, significant research effort is currently focused on developing multiplexed architectures to increase the number of biomarkers that could be screened simultaneously to improve the confidence interval of the analysis. However, for current clinical techniques such as ELISA, a major cost lies in the quantity of reagents, particularly antibodies, required to functionalize the surface. , Although significant focus is given in the literature on ways of improving biosensor performance, little attention has been paid to date to creating sensing architectures that limit the quantity of reagents required for analysis without loss in sensitivity or specificity.…”
Section: Introductionmentioning
confidence: 99%
“…16−20 However, for current clinical techniques such as ELISA, a major cost lies in the quantity of reagents, particularly antibodies, required to functionalize the surface. 21,22 Although significant focus is given in the literature on ways of improving biosensor performance, little attention has been paid to date to creating sensing architectures that limit the quantity of reagents required for analysis without loss in sensitivity or specificity.…”
Section: ■ Introductionmentioning
confidence: 99%
“…While the enzyme-linked immunosorbent assay (ELISA) approach is a popular and precise technique widely applied for immunodetection of antigen molecules in diagnostic applications, immunosensors with MNP amplification can be potentially substituted for conventional ELISA kits, offering same or even better sensitivity, lower detection time, and minimal washing steps [77, 78]. Jeong et al [79] developed a highly sensitive electrochemical immunosensor for determination of the carcinoembryonic antigen (CEA) cancer biomarker through immobilizing the first antibody and a mediator (thionine, Th) on a AuNP-encapsulated dendrimer (Den/AuNP) and immobilizing the second antibody on MWCNTs, which were in turn conjugated with two enzymes, glucose oxidase (GOx) and horseradish peroxidase (HRP) as electrochemical labels.…”
Section: The Functions Of Mnps In Various Biosensor Typesmentioning
confidence: 99%
“…Além disso, a diversidade de alimentos disponíveis, a adição de nutrientes, a adulteração acidental ou deliberada e a demanda por produtos mais saudáveis por parte do consumidor contribuem para o desenvolvimento das pesquisas em biossensores. 142 Novas tecnologias específicas como biossensores acoplados a celulares 144 44,148,149 , microeletrodos e eletrodos descartáveis 55,96,150 foram desenvolvidas para esse mercado nos últimos anos e são capazes de fornecer informações específicas sobre possíveis contaminações como defensivos agrícolas, metais pesados, poluentes e compostos tóxicos, além da qualidade do produto final. [151][152][153]…”
Section: Munclassified